98%
921
2 minutes
20
The complaints of people suffering from Insomnia Disorder (ID) concern both sleep and daytime functioning. However, little is known about wake brain temporal dynamics in people with ID. We therefore assessed possible alterations in Long-Range Temporal Correlations (LRTC) in the amplitude fluctuations of band-filtered oscillations in electroencephalography (EEG) recordings. We investigated whether LRTC differ between cases with ID and matched controls. Within both groups, we moreover investigated whether individual differences in subjective insomnia complaints are associated with LRTC. Resting-state high-density EEG (256-channel) was recorded in 52 participants with ID and 43 age- and sex-matched controls, during Eyes Open (EO) and Eyes Closed (EC). Detrended fluctuation analysis was applied to the amplitude envelope of band-filtered EEG oscillations (theta, alpha, sigma, beta-1, beta-2) to obtain the Hurst exponents (), as measures of LRTC. Participants rated their subjective insomnia complaints using the Insomnia Severity Index (ISI). Through general linear models, we evaluated whether , aggregated across electrodes and frequencies, differed between cases and controls, or showed within-group associations with individual differences in ISI. Additionally, we characterized the spatio-spectral profiles of group differences and associations using non-parametric statistics. did not differ between cases with ID and controls in any of the frequency bands, neither during EO nor EC. During EO, however, within-group associations between and ISI indicated that individuals who experienced worse sleep quality had stronger LRTC. Spatio-spectral profiles indicated that the associations held most prominently for the amplitude fluctuations of parietal theta oscillations within the ID group, and of centro-frontal beta-1 oscillations in controls. While people suffering from insomnia experience substantially worse sleep quality than controls, their brain dynamics express similar strength of LRTC. In each group, however, individuals experiencing worse sleep quality tend to have stronger LRTC during eyes open wakefulness, in a spatio-spectral range specific for each group. Taken together, the findings indicate that subjective insomnia complaints involve distinct dynamical processes in people with ID and controls. The findings are in agreement with recent reports on decreasing LRTC with sleep depth, and with the hypothesis that sleep balances brain excitability.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126110 | PMC |
http://dx.doi.org/10.3389/fphys.2016.00576 | DOI Listing |
J Natl Cancer Inst
September 2025
Centre Francois Baclesse, Medical oncology department, University UniCaen, Anticipe U1086 Inserm, Caen, France.
Background: Breast cancer (BC) survivors receiving adjuvant treatments often report clinically relevant cancer-related cognitive complaints (CRCC), which have a significant impact on quality of life. We aimed to develop a comprehensive model of prediction of CRCC, including clinical and serum inflammatory protein data.
Methods: We included 9575 stage I-III BC patients from the CANTO cohort (NCT01993498).
Cureus
July 2025
Department of Pharmaceutical Services, Hiroshima University Hospital, Hiroshima, JPN.
Introduction Insomnia is a common clinical complaint, often presenting with symptoms such as difficulty initiating sleep, frequent nighttime awakenings, early morning awakenings, or non-restorative sleep. These disturbances are frequently associated with a range of psychiatric and physical conditions and may contribute to reduced quality of life and broader societal burden. Although benzodiazepines (BZ) are commonly used to manage inpatient insomnia, their use, especially in older adults, has been associated with adverse outcomes such as cognitive impairment, falls, and fractures.
View Article and Find Full Text PDFZh Nevrol Psikhiatr Im S S Korsakova
August 2025
Ural State Medical University, Yekaterinburg, Russia.
Objective: To analyze the incidence of new-onset sleep disorders after novel coronavirus infection (COVID-19) in patients with primary headaches.
Material And Methods: A prospective case-control study was conducted from May 2022 to July 2024 using a semi-structured interview with 212 patients with primary headaches and complaints of sleep problems with a history of COVID-19 (main group, =135 patients, 98% women, mean age 46.3 years) and without COVID-19 (control group, =77, 54% women, mean age 45.
Sleep Med Rev
October 2025
Department of Psychiatry, Faculty of Medicine, University of Geneva, Switzerland; Department of Psychiatry, Geneva University Hospitals (HUG), Geneva, Switzerland.
Insomnia disorder is a prevalent health problem with adverse consequences for mental health and quality of life. Although insomnia disorder is defined in diagnostic systems as a subjective complaint about sleep, this understanding is not consistently applied in clinical settings. There remains a lack of clarity regarding the mechanisms underlying subjective sleep complaints and associated daytime impairments.
View Article and Find Full Text PDFJ Pain Symptom Manage
August 2025
Department of Pain Medicine, University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address:
Context: Low dose naltrexone (LDN) has been utilized off-label for chronic non-cancer pain; its benefits in treating cancer-related pain remain unclear.
Objectives: We describe the safety and effectiveness of LDN therapy from initiation to the first two follow-up visits in treating refractory cancer-pain.
Methods: Medical charts of cancer patients seen in the Pain Management Center who were prescribed LDN between 2022 and 2023 were reviewed.